+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

United States Cannabis Market - Legalization Trends & Forecast 2025-2033

  • PDF Icon

    Report

  • 200 Pages
  • June 2025
  • Region: United States
  • Renub Research
  • ID: 6101844
United States Cannabis Market is expected to reach US$ 91.10 billion by 2033 from US$ 36.94 billion in 2024, with a CAGR of 10.55% from 2025 to 2033. Increased state-by-state legalization, an increase in medical applications, consumer acceptance, product innovation, growing retail infrastructure, investment inflows, favorable regulatory reforms, and the transition from illegal to legal markets are some of the major factors propelling the U.S. cannabis market.

United States Cannabis Market Report by Source (Marijuana, Hemp), Derivatives (CBD, THC, Others), End Use (Recreational, Medical, Industrial), States and Company Analysis 2025-2033.

United States Cannabis Market Overview

The psychotropic and therapeutic qualities of cannabis, a genus of plants, are mostly attributed to substances known as cannabinoids, which include THC (tetrahydrocannabinol) and CBD (cannabidiol). While CBD is non-intoxicating and often used medically, THC is psychoactive. This plant is used in many ways-from lotions applied topically, to ingested goods and its use as an oil, to smoking it. It has been known to be used to treat epilepsy and chronic pain, not to mention anxiety, but also simply for fun. For thousands of years, people have cultivated the plant for its medicinal, industrial (hemp), and spiritual uses. Legal status is different across the globe, and its increasing commercialization is due to rising acceptability and legalization.

The US cannabis market is increasing tremendously because of a variety of significant causes. One of the primary drivers is the broadening of legalization for both medical and adult-use in various states. It is also being driven by changing societal attitudes towards cannabis and increasing public acceptability. Product innovation breakthroughs such as beverages, edibles, and health products are attracting a broader base of consumers. Infrastructure and distribution channels are also being enhanced by investments from the institutional and private sectors. Market confidence is also supported by regulatory enhancements and potential federal legalization. Although increasing use for medicinal purposes drives continued interest, making the shift from illicit to legitimate marketplaces creates new revenue.

Growth Drivers for the United States Cannabis Market

Public Acceptance

The US cannabis market is growing enormously because, in large part, public acceptance is driving it. Increasing numbers of Americans find that using cannabis is socially acceptable and medically beneficial as attitudes about it continue to shift. Demand is being created and policy reform is being driven by this shift in culture. Based on merged data for 2022 and 2023, the Gallup Survey approximates that more than half of American adults, of both sexes, all age ranges, and all educational levels, have used marijuana. Such widespread exposure is indicative of greater acceptance of legal cannabis use and stigma loss. More customers are joining the legal market as acceptance grows, which boosts company expansion, draws in investment, and promotes additional legalization across states, all of which hasten market growth.

State-Level Legalization

Legalization at the state level allows more states to create regulated medicinal and recreational cannabis programs, which is a major growth driver for the US cannabis business. This steady growth draws investments, promotes innovation, and makes the market more accessible. Governor Kathy Hochul announced in June 2023 that Chicago Atlantic Admin, LLC would advance social equity applications and foster inclusive industry development by investing up to USD 150 million into the New York State Cannabis Social Equity Investment Fund. In addition, Dutchie, Inc., an Oregon-based cannabis technology company, raised approximately USD 350 million in Series D funding in 2021, as per Reuters, indicating the strong faith investors have in the cannabis sector. These developments indicate how legalization at the state level encourages market growth through the integration of large capital flows, social justice initiatives, and advances in regulations.

Product Innovation

A major growth driver in the U.S. cannabis market is product innovation, driven by businesses developing a variety of products that will meet ever-changing consumer demands. As part of its expansion, Rodedawg International Industries, Inc. added a new product line, Nutrient CBD, in June 2024. Five new products entered the market, namely two CBD oil tinctures and two CBD creams, together with a CBD roll-on. They are produced by proprietary formulas in-house in the company's facilities, ensuring consistency and high quality and attracting health-aware customers.

Challenges in the United States Cannabis Market

Public Health Concerns

One major obstacle facing the US cannabis sector is public health concerns. Experts and authorities are concerned about increased youth access, impaired driving, and possible long-term mental health impacts, especially with high-THC products, as legalization spreads. Particularly when it comes to edibles, inconsistent product testing and labeling can result in unintentional overconsumption. Furthermore, a thorough grasp of cannabis's health effects is hampered by the absence of thorough research because of federal regulations. These worries fuel opposition from lawmakers and health groups, which could impede legislative advancement and alter public opinion, so limiting industry expansion and consumer adoption.

Market Saturation

In the US cannabis business, market saturation is becoming a problem, especially in states where the sector is developed or growing quickly. When the number of authorized producers, dispensaries, and cultivators rises, supply frequently surpasses demand, which lowers wholesale and retail costs. Profit margins are under pressure from this fierce competition, particularly for small and mid-sized enterprises. Oversupply in some areas has resulted in product surpluses and operator financial instability. Price wars and a lack of distinctiveness also hinder the success of new competitors. In the absence of prudent regulation and market equilibrium, saturation could impede long-term expansion and result in company closures and consolidation.

California Cannabis Market

California's cannabis industry, which combines entrepreneurship, wellness, and culture, thrives on variety and innovation. From innovative concentrates to artisanal edibles, the state's changing legal landscape promotes innovative product creation to appeal to a wide range of consumers. Enthusiastic producers and retailers continue to be dedicated to quality and sustainability in spite of legal complexity and competition from unauthorized dealers. By addressing historical injustices, social equity initiatives seek to promote diversity in the sector. Both locals and visitors are drawn to California because of its deeply ingrained cannabis culture. As the market develops, it keeps striking a balance between history and modernity, establishing trends that affect the cannabis industry nationwide.

Texas Cannabis Market

The cannabis industry in Texas is still developing slowly due to stringent laws and conservative attitudes. Although cannabis is not yet legal for recreational use, attitudes are changing as medicinal cannabis and CBD products gain traction. Due to the market's restricted legal access, many customers are being driven to other sources. Advocates and entrepreneurs are actively interacting to shape upcoming legislative changes. Once regulations loosen, Texas' sizable population and robust economy point to substantial market expansion possibilities. Gradual expansion is also aided by growing public awareness and product innovation resulting from hemp. The cannabis environment in Texas is a special fusion of openness, limitations, and continuous discussion.

New York Cannabis Market

The cannabis market in New York is quickly developing into a vibrant, diverse sector. Since legalizing cannabis for adult use, the state has prioritized fostering fair opportunities, awarding a sizable percentage of licenses to members of groups that have been disproportionately affected by cannabis prohibition. The goal of this strategy is to support a locally owned and diverse cannabis industry. The state's dedication to fairness and inclusion keeps its cannabis business moving forward in spite of obstacles including legal barriers and competition from the black market. New York is setting itself up as a model for other states looking to create equitable and long-lasting cannabis marketplaces as the industry develops.

Recent Developments in United States Cannabis Market

  • British American Tobacco PLC and botanical medicinal development company AJNA BioSciences PBC established a joint venture with Charlotte's Web, a U.S.-based business, in April 2023. Getting FDA approval for a full spectrum hemp extract botanical medication was the goal of the acquisition.
  • CV Sciences, Inc. introduced its +PlusCBD reserve line of extra gummies in April 2023. When severe assistance is needed, the reserve collection product line's blend of full-spectrum cannabinoids can help.
  • CV Sciences, Inc. debuted +PlusCBD Daily Balance THC-Free Softgels and Gummies in March 2023. The product is a daily, portable supplement that offers the wellness advantages of CBD.

Market Segmentation

Source

  • Marijuana
  • Hemp

Derivatives

  • CBD
  • THC
  • Others

End Use

  • Recreational
  • Medical
  • Industrial

States

  • California
  • Texas
  • New York
  • Florida
  • Illinois
  • Pennsylvania
  • Ohio
  • Georgia
  • Washington
  • New Jersey
  • Rest of United States

All companies have been covered from 5 viewpoints:

  • Company Overview
  • Key Persons
  • Recent Development & Strategies
  • SWOT Analysis
  • Sales Analysis

Key Players Analysis

  • Charlotte's Web, Inc.
  • Medical Marijuana, Inc.
  • Canopy Growth Corporation
  • NuLeaf Naturals, LLC
  • CV Sciences, Inc.
  • The Cronos Group
  • Organigram Holding, Inc.
  • Irwin Naturals
  • Tilray Brands
  • Aurora Cannabis Inc.

Table of Contents

1. Introduction
2. Research & Methodology
2.1 Data Source
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Research Approach
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.3 Forecast Projection Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. United States Cannabis Market
5.1 Historical Market Trends
5.2 Market Forecast
6. Market Share Analysis
6.1 By Source
6.2 By Derivatives
6.3 By End Use
6.4 By States
7. Source
7.1 Marijuana
7.1.1 Market Analysis
7.1.2 Market Size & Forecast
7.2 Hemp
7.2.1 Market Analysis
7.2.2 Market Size & Forecast
8. Derivatives
8.1 CBD
8.1.1 Market Analysis
8.1.2 Market Size & Forecast
8.2 THC
8.2.1 Market Analysis
8.2.2 Market Size & Forecast
8.3 Others
8.3.1 Market Analysis
8.3.2 Market Size & Forecast
9. End Use
9.1 Recreational
9.1.1 Market Analysis
9.1.2 Market Size & Forecast
9.2 Medical
9.2.1 Market Analysis
9.2.2 Market Size & Forecast
9.3 Industrial
9.3.1 Market Analysis
9.3.2 Market Size & Forecast
10. Countries
10.1 California
10.1.1 Market Analysis
10.1.2 Market Size & Forecast
10.2 Texas
10.2.1 Market Analysis
10.2.2 Market Size & Forecast
10.3 New York
10.3.1 Market Analysis
10.3.2 Market Size & Forecast
10.4 Florida
10.4.1 Market Analysis
10.4.2 Market Size & Forecast
10.5 Illinois
10.5.1 Market Analysis
10.5.2 Market Size & Forecast
10.6 Pennsylvania
10.6.1 Market Analysis
10.6.2 Market Size & Forecast
10.7 Ohio
10.7.1 Market Analysis
10.7.2 Market Size & Forecast
10.8 Georgia
10.8.1 Market Analysis
10.8.2 Market Size & Forecast
10.9 Washington
10.9.1 Market Analysis
10.9.2 Market Size & Forecast
10.10 New Jersey
10.10.1 Market Analysis
10.10.2 Market Size & Forecast
10.11 Rest of United States
10.11.1 Market Analysis
10.11.2 Market Size & Forecast
11. Value Chain Analysis12. Regulatory Scenario13. Licensing Scenario in the United States
14. Government Policy Designing Cannabis Guidelines
14.1 Federal Cannabis Policy
14.2 Policy Challenges and Opportunities
15. Reimbursement Policies in the United States16. Taxation Policies in the United States
17. Porter's Five Forces Analysis
17.1 Bargaining Power of Buyers
17.2 Bargaining Power of Suppliers
17.3 Degree of Competition
17.4 Threat of New Entrants
17.5 Threat of Substitutes
18. SWOT Analysis
18.1 Strength
18.2 Weakness
18.3 Opportunity
18.4 Threats
19. Pricing Benchmark Analysis
19.1 Charlotte's Web, Inc.
19.2 Medical Marijuana, Inc.
19.3 Canopy Growth Corporation
19.4 NuLeaf Naturals, LLC
19.5 CV Sciences, Inc.
19.6 The Cronos Group
19.7 Organigram Holding, Inc.
19.8 Irwin Naturals
19.9 Tilray Brands
19.10 Aurora Cannabis Inc.
20. Key Players Analysis
20.1 Charlotte's Web, Inc.
20.1.1 Overviews
20.1.2 Key Person
20.1.3 Recent Developments
20.1.4 SWOT Analysis
20.1.5 Revenue Analysis
20.2 Medical Marijuana, Inc.
20.2.1 Overviews
20.2.2 Key Person
20.2.3 Recent Developments
20.2.4 SWOT Analysis
20.2.5 Revenue Analysis
20.3 Canopy Growth Corporation
20.3.1 Overviews
20.3.2 Key Person
20.3.3 Recent Developments
20.3.4 SWOT Analysis
20.3.5 Revenue Analysis
20.4 NuLeaf Naturals, LLC
20.4.1 Overviews
20.4.2 Key Person
20.4.3 Recent Developments
20.4.4 SWOT Analysis
20.4.5 Revenue Analysis
20.5 CV Sciences, Inc.
20.5.1 Overviews
20.5.2 Key Person
20.5.3 Recent Developments
20.5.4 SWOT Analysis
20.5.5 Revenue Analysis
20.6 The Cronos Group
20.6.1 Overviews
20.6.2 Key Person
20.6.3 Recent Developments
20.6.4 SWOT Analysis
20.6.5 Revenue Analysis
20.7 Organigram Holding, Inc.
20.7.1 Overviews
20.7.2 Key Person
20.7.3 Recent Developments
20.7.4 SWOT Analysis
20.7.5 Revenue Analysis
20.8 Irwin Naturals
20.8.1 Overviews
20.8.2 Key Person
20.8.3 Recent Developments
20.8.4 SWOT Analysis
20.8.5 Revenue Analysis
20.9 Tilray Brands
20.9.1 Overviews
20.9.2 Key Person
20.9.3 Recent Developments
20.9.4 SWOT Analysis
20.9.5 Revenue Analysis
20.10 Aurora Cannabis Inc.
20.10.1 Overviews
20.10.2 Key Person
20.10.3 Recent Developments
20.10.4 SWOT Analysis
20.10.5 Revenue Analysis

Companies Mentioned

  • Charlotte's Web, Inc.
  • Medical Marijuana, Inc.
  • Canopy Growth Corporation
  • NuLeaf Naturals, LLC
  • CV Sciences, Inc.
  • The Cronos Group
  • Organigram Holding, Inc.
  • Irwin Naturals
  • Tilray Brands
  • Aurora Cannabis Inc.

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Table Information